Table of Contents

Serotonin 2B Receptors in Mesoaccumbens Dopamine Pathway Regulate Cocaine Responses

  1. Luc Maroteaux1,2,3
  1. 1Institut national de la santé et de la recherche médicale, Unité Mixte de Recherche-S839, F-75005 Paris, France,
  2. 2Sorbonne Universités, Universite Pierre et Marie Curie (Paris VI), Unité Mixte de Recherche-S839, F-75005 Paris, France,
  3. 3Institut du Fer à Moulin, F-75005 Paris, France,
  4. 4Neuroscience Paris Seine, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8246, Institut national de la santé et de la recherche médicale, U1130, F-75794 Paris, France,
  5. 5Sorbonne Universités, Universite Pierre et Marie Curie (Paris VI), Unité Mixte de Recherche 7102, F-75005 Paris, France,
  6. 6Assistance Publique Hôpitaux de Paris, Hôpital Lariboisière, Service de Biochimie, F-75010 Paris, France,
  7. 7Institut national de la santé et de la recherche médicale, U942, F-75010 Paris, France,
  8. 8Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, University Pompeu Fabra, Barcelona 08003, Spain, and
  9. 9Integrative Pharmacology and Systems Neuroscience, IMIM–Hospital del Mar Research Institute, 08003 Barcelona, Spain
  1. Author contributions: P.F., D.H., P.R., M.M., R.M., and L.M. designed research; S.D., E.Q., R.E., S.T., S.P.F., J.B.-G., E.V., A.B., X.V., J.C., F.J.M., P.R., and J.-M.L. performed research; S.D., S.P.F., J.B.-G., E.V., and A.B. contributed unpublished reagents/analytic tools; S.D., E.Q., R.E., S.T., S.P.F., J.B.-G., A.B., X.V., J.C., P.F., F.J.M., D.H., P.R., M.M., J.-M.L., R.M., and L.M. analyzed data; S.D., J.B.-G., P.F., F.J.M., D.H., P.R., M.M., R.M., and L.M. wrote the paper.

  • S.D.'s present address: Université Clermont Auvergne, INSERM, NEURO-DOL, F-63000 Clermont-Ferrand, France.

  • S.P.F's present address: IPMC–CNRS UMR7275, 660 Route des Lucioles Sophia-Antipolis, 06560 Valbonne France.

  • J.B.-G.'s present address: Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, The University of Queensland, Brisbane, Queensland 4067, Australia.

  • E.V.'s present address: Institut de Génomique Fonctionnelle, INSERM U661; CNRS UMR 5203; University Montpellier I and II, Montpellier, France.

  • A.B's present address: Translational Research Institute, Queensland University of Technology, Brisbane, Queensland 4059, Australia.

  • M.M.'s present address: Department of Fundamental Neurosciences, The University of Lausanne, Rue du Bugnon 9, 1005 Lausanne, Switzerland.

Abstract

Addiction is a maladaptive pattern of behavior following repeated use of reinforcing drugs in predisposed individuals, leading to lifelong changes. Common among these changes are alterations of neurons releasing dopamine in the ventral and dorsal territories of the striatum. The serotonin 5-HT2B receptor has been involved in various behaviors, including impulsivity, response to antidepressants, and response to psychostimulants, pointing toward putative interactions with the dopamine system. Despite these findings, it remains unknown whether 5-HT2B receptors directly modulate dopaminergic activity and the possible mechanisms involved. To answer these questions, we investigated the contribution of 5-HT2B receptors to cocaine-dependent behavioral responses. Male mice permanently lacking 5-HT2B receptors, even restricted to dopamine neurons, developed heightened cocaine-induced locomotor responses. Retrograde tracing combined with single-cell mRNA amplification indicated that 5-HT2B receptors are expressed by mesolimbic dopamine neurons. In vivo and ex vivo electrophysiological recordings showed that 5-HT2B-receptor inactivation in dopamine neurons affects their neuronal activity and increases AMPA-mediated over NMDA-mediated excitatory synaptic currents. These changes are associated with lower ventral striatum dopamine activity and blunted cocaine self-administration. These data identify the 5-HT2B receptor as a pharmacological intermediate and provide mechanistic insight into attenuated dopamine tone following exposure to drugs of abuse.

SIGNIFICANCE STATEMENT Here we report that mice lacking 5-HT2B receptors totally or exclusively in dopamine neurons exhibit heightened cocaine-induced locomotor responses. Despite the sensitized state of these mice, we found that associated changes include lower ventral striatum dopamine activity and lower cocaine operant self-administration. We described the selective expression of 5-HT2B receptors in a subpopulation of dopamine neurons sending axons to the ventral striatum. Increased bursting in vivo properties of these dopamine neurons and a concomitant increase in AMPA synaptic transmission to ex vivo dopamine neurons were found in mice lacking 5-HT2B receptors. These data support the idea that the chronic 5-HT2B-receptor inhibition makes mice behave like animals already exposed to cocaine with higher cocaine-induced locomotion associated with changes in dopamine neuron reactivity.

  • Received May 18, 2017.
  • Revision received September 12, 2017.
  • Accepted September 13, 2017.
Responses to This Article
Be the first to respond to this article
Advertisement